Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
- Status
- RECRUITING
- Phase
- PHASE2
Multimodal Ultrasound and Hepatocellular Response to Local Treatments
- Status
- UNKNOWN
- Phase
- NA
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
- Status
- RECRUITING
- Phase
- NA
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC
- Status
- RECRUITING
- Phase
- NA
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery
- Status
- UNKNOWN
- Phase
- N/A
Predictors of Sorafenib Response in HCC
- Status
- UNKNOWN
- Phase
- N/A
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens
- Status
- RECRUITING
- Phase
- N/A
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators
- Status
- UNKNOWN
- Phase
- N/A
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2